Pharma Business Updates
Hims Won't Back Down From Selling Cheap Weight-Loss Shots
June 25, 2025 at 10:26
Andrew Dudum said his company won’t back down from selling cheap weight-loss shots.
Hims & Hers Health Inc. won’t back down from selling cheap weight-loss shots, its chief executive officer said one day after Novo Nordisk A/S abruptly ended its distribution partnership.
“We’re upset that Novo is feeling the pressure and not comfortable, but ultimately, I think us holding strong to fighting on behalf of customers is just who we are,” Hims CEO Andrew Dudum said Tuesday in his first interview since the news broke. “There’s just no way in hell we’re going to cave on that, no matter who the pharma company is or what the partnership looks like.”
Keywords
Newer articles
In case you missed it
<p> The Middle East archrivals will end their “12-day war,” the US president wrote on his Truth Social platform</p>
Sanchez and Bezos’ Venetian wedding
Kenyans Return to the Streets a Year After Deadly Tax Protests
The Bezos-Sánchez Wedding and the Triumph of Tacky
Israel and Iran agree to ceasefire to bring end to '12 DAY WAR,' Trump says
US supreme court clears way for Trump to deport migrants to countries not their own
Behind Closed Doors, Harvard Officials Debate a Risky Truce With Trump
Inside a plan to use AI to amplify doubts about the dangers of pollutants
How Qatar Helped Broker the Israel-Iran Cease-Fire
US rests case against Sean ‘Diddy’ Combs in sex-trafficking and racketeering trial